A highly analytical, detail-oriented, and tech-savvy Physics with Electronics graduate with an exceptional academic record (3.98 CGPA) and proven capability in talent sourcing, human resources, and administrative operations. Blends rigorous quantitative reasoning and data analysis skills with practical experience managing end-to-end recruitment pipelines and virtual workflows. A certified project manager adept at leveraging data tools (Excel, Power BI, Python) to optimize processes, improve organizational efficiency, and support cross-functional teams. Proven leader and proactive problem-solver prepared to excel in graduate trainee, HR, tech-support, and operations roles.

Innovations In Vaccine Development for Emerging Infectious Diseases: From Platform Technologies to Rapid Pandemic Response (2015–2025):                                                           

Emerging infectious diseases can spread faster than conventional vaccine-development systems can respond. The 2014–2016 West African Ebola outbreak and the COVID-19 pandemic demonstrated the consequences of this gap, but they also showed what is possible when science, manufacturing, regulation and global cooperation are prepared in advance. Between 2015 and 2025, vaccine research moved increasingly toward flexible platform technologies rather than developing every vaccine from the beginning. mRNA and viral-vector platforms, reverse vaccinology, structure-based antigen design, nanoparticle delivery, self-amplifying RNA and artificial intelligence have shortened or simplified important parts of the vaccine-development pathway. The COVID-19 experience provided the clearest proof of concept: two mRNA vaccines were developed, evaluated and deployed at unprecedented speed. However, speed alone does not guarantee equitable access. Cold-chain requirements, manufacturing capacity, financing, regulatory readiness, clinical-trial infrastructure and public trust remain major barriers, particularly in low and middle-income countries. This review argues that the next generation of pandemic preparedness should combine rapid vaccine platforms with strong surveillance, local manufacturing, clinical networks and routine public-health measures.

Keywords: mRNA vaccines, viral-vector platforms, reverse vaccinology, structural design, AI and rapid-response strategies